<sentence id="0">Expression of biologically active human factor VIII using a baculovirus vector .</sentence>
<sentence id="1">Factor VIII is a complex , plasma glycoprotein involved in the process of blood coagulation .</sentence>
<sentence id="2">Production of the recombinant molecule has largely been confined to mammalian cell systems which have , in general , proven to be inefficient producers of factor VIII .</sentence>
<sentence id="3">The use of a baculovirus expression system <scope type="spec" id="1"> <cue type="spec" id="1">may</cue> provide increased levels of this glycoprotein</scope> , although it is <scope type="neg" id="0"><cue type="neg" id="0">not</cue> certain that insect cell-derived factor VIII will be biologically active</scope> .</sentence>
<sentence id="4">The N-linked glycosylation patterns in insect cells , until recently <scope type="spec" id="2"> <cue type="spec" id="2">thought</cue> to be less complex than in mammalian cells</scope> , <scope type="spec" id="3"> <cue type="spec" id="3">may</cue> influence activity and/or secretory ability</scope> .</sentence>
<sentence id="5">To this end we engineered a B domain-deleted factor VIII cDNA sequence for expression in Spodoptera frugiperda cells .</sentence>
<sentence id="6">The construct retained the native signal sequence to allow secretion of recombinant protein into the culture medium .</sentence>
<sentence id="7">Initial studies revealed the production of secreted factor VIII , and this protein was shown to possess coagulation activity .</sentence>
<sentence id="8">The presence of N-linked oligosaccharide residues was demonstrated , the glycosylated molecule being of a similar size to that expressed in mammalian cells .</sentence>